LY-393558

N/A

Report date: 2023/09/27 09:15:18
NME

Base Information

Drug NameLY-393558
Drug Alias NameLY-393558
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1b (5-HT1b) receptor antagonistsSerotonin 1d (5-HT1d) receptor antagonistsSerotonin reuptake inhibitors
TargetsSerotonin 1b (5-HT1b) receptorSerotonin 1d (5-HT1d) receptorSerotonin transporter
Therapy Area/IndicationsDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsDepressive Disorder

Other Information

ATC CodeN/A
Related LinksN/A